Vaccination is one of the most effective prophylactic public health interventions for the
prevention of infectious diseases such as coronavirus disease (COVID‐19). Considering the …

The sudden emergence of SARS-CoV-2 demonstrates the need for new vaccines that
rapidly protect in the case of an emergency. In this study, we developed a recombinant MVA …

Human cytomegalovirus (CMV) is the most common infectious cause of complications post-
transplantation, while a CMV vaccine for transplant recipients has yet to be licensed. Triplex …

Smallpox was eradicated in less than 200 years after Edward Jenner's practice of cowpox
variolation in 1796. The forty-three years of us living free of smallpox, beginning in 1979 …

Background Although the mpox global health emergency caused by mpox virus (MPXV)
clade IIb. 1 has ended, mpox cases are still reported due to low vaccination coverage and …

The constant appearance of new severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variants of concern (VoCs) has jeopardized the protective capacity of approved …

Aging is associated with a decline in immune system functionality. So-called
immunosenescence may impair the successful vaccination of elderly people. Thus …

Hematopoietic cell transplantation (HCT) and chimeric antigen receptor (CAR)-T cell
patients are immunocompromised, remain at high risk following SARS-CoV-2 infection, and …

Preclinical studies indicate that SARS-CoV-2 nucleocapsid (N)-based vaccines, along with
other viral protein (s), confer protection in various animal models against infection by SARS …